This work thus emphasizes that narcolepsy pathogenesis is strongly mediated by the immune system (i.e., CTLs play a central effector role) and suggests that novel therapeutic strategies including OXA should trigger the protection of orexin-secreting neurons. The gene discussed is HCRT; the disease is narcolepsy.